NADPH-dependent oxidation of benzidine by rat liver.

This study used liver microsomes from control an naphthoflavone-treated rats to evaluate NADPH-dependent oxidation of benzidine. With microsomes from beta-naphthoflavone-treated rats, the rates of formation of aqueous soluble metabolite (HPLC analysis) and protein and DNA binding were 835 +/- 81, 14.5 +/- 1.8 and 0.71 +/- 0.14 pmol/mg/min respectively. beta-Naphthoflavone treatment elicited 12.3-, 1.8- and 14.2-fold increases in benzidine metabolism compared with controls as judged by HPLC and protein and DNA binding respectively. For microsomes from treated animals, Km and Vmax values were 47 +/- 6 micromol and 1.13 +/- 0.16 nmol/mg protein/min respectively. All of the metabolic parameters were inhibited to varying degrees by glutathione (1 or 10 mM), N-acetylmethionine (10 mM) and ascorbic acid (10 mM). Following glutathione addition, at least two new metabolite peaks were observed, representing -6% of the total radioactivity recovered by HPLC. Neither metabolite was 3-(glutathion-S-yl)benzidine. Cytochrome P450 inhibitors (10 micro) specific for different members of cytochrome gene families 1-3 indicated that benzidine was metabolized by cytochrome P450 1A1/1A2. Ellipticine and alpha-naphthoflavone, specific 1A1/1A2 inhibitors, elicited 50% inhibition at -0.2 and 0.5 micro respectively. Electron impact and negative ion chemical ionization mass spectro- metry identified the aqueous soluble metabolite as 3-hydroxybenzidine. The lability of 3-hydroxybenzidine observed at pH > 7.0 was prevented by ascorbic acid. Thus, cytochrome P450 1A1/1A2 NADPH-dependent metabolism of benzidine to 3-hydroxybenzidine was demonstrated.

[1]  R. Hayes,et al.  The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Hayes,et al.  Determination of benzidine, N-acetylbenzidine, and N,N'-diacetylbenzidine in human urine by capillary gas chromatography/negative ion chemical ionization mass spectrometry. , 1996, Analytical biochemistry.

[3]  D. Bell,et al.  N-acetylbenzidine and N,N'-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. , 1995, Carcinogenesis.

[4]  F. Hsu,et al.  The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. , 1995, Chemical research in toxicology.

[5]  V. Lakshmi,et al.  Mechanism of 3-(glutathion-S-yl)-benzidine formation. , 1994, Toxicology and applied pharmacology.

[6]  D. Schrenk,et al.  Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes. , 1994, Carcinogenesis.

[7]  P. E. Hanna,et al.  Bioactivation of N-hydroxy-2-acetylaminofluorenes by N,O-acyltransferase: substituent effects on covalent binding to DNA. , 1993, Carcinogenesis.

[8]  Josephy Pd,et al.  Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. , 1992 .

[9]  D. Grant,et al.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Lakshmi,et al.  Mechanism of peroxidative activation of the bladder carcinogen 2-amino-4-(5-nitro-2-furyl)-thiazole (ANFT): comparison with benzidine. , 1990, Carcinogenesis.

[11]  T. Deguchi,et al.  Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. , 1990, The Journal of biological chemistry.

[12]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Kadlubar,et al.  Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. , 1989, Cancer research.

[14]  D. Miller,et al.  Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. , 1988, Carcinogenesis.

[15]  D. Hein.  Acetylator genotype and arylamine-induced carcinogenesis. , 1988, Biochimica et biophysica acta.

[16]  J. S. Patel,et al.  Benzidine and its acetylated metabolites in the urine of workers exposed to Direct Black 38. , 1988, Archives of environmental health.

[17]  R. Gupta,et al.  Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Williams,et al.  Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines. , 1986, Molecular pharmacology.

[19]  A. Danon,et al.  Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer. , 1986, Cancer research.

[20]  R. Gupta,et al.  Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. , 1985, Cancer research.

[21]  A. Elfarra,et al.  Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase. , 1985, Journal of medicinal chemistry.

[22]  F. Beland,et al.  DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. , 1985, Carcinogenesis.

[23]  F. Guengerich,et al.  Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. , 1985, Cancer research.

[24]  F. Kadlubar,et al.  Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. , 1985, Carcinogenesis.

[25]  T. Zenser,et al.  Prostaglandin H synthase oxidation of benzidine and o-dianisidine: reduction and conjugation of activated amines by thiols. , 1985, Carcinogenesis.

[26]  W. Weber,et al.  N-acetylation pharmacogenetics. , 1985, Pharmacological reviews.

[27]  T. Zenser,et al.  Characterization of benzidinediimine: a product of peroxidase metabolism of benzidine. , 1984, Carcinogenesis.

[28]  F. Kadlubar,et al.  Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. , 1984, Cancer research.

[29]  M. Bhatt,et al.  Cleavage of Ethers , 1983 .

[30]  K. F. Scott,et al.  Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[31]  F. Kadlubar,et al.  Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. , 1982, Biochemical and biophysical research communications.

[32]  F. Guengerich,et al.  Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.

[33]  H. Armbrecht,et al.  Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. , 1980, Cancer research.

[34]  T. Zenser,et al.  Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. , 1979, The Journal of pharmacology and experimental therapeutics.

[35]  T. Zenser,et al.  Differential distribution of the mixed-function oxidase activities in rabbit kidney. , 1978, The Journal of pharmacology and experimental therapeutics.

[36]  E. Bingham,et al.  Benzidine exposure as a cause of bladder tumors. , 1973, Archives of environmental health.

[37]  J. Miller,et al.  Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. , 1972, Biochimica et biophysica acta.

[38]  Meigs Jw,et al.  The biotransformation of benzidine. II. Studies in mouse and man. , 1961 .

[39]  W. Troll,et al.  Studies on aromatic amines. I. Preliminary observations on benzidine metabolism. , 1958, American Industrial Hygiene Association journal.

[40]  L. J. Sciarini.  3-Hydroxybenzidine, a metabolite of benzidine. , 1957, Archives of biochemistry and biophysics.

[41]  M. E. Hosker,et al.  Tumours of the Urinary Bladder , 1936, The Indian Medical Gazette.

[42]  R. Hayes,et al.  Mortality and incidence of bladder cancer in benzidine-exposed workers in China. , 1992, American journal of industrial medicine.

[43]  D. Grant,et al.  Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. , 1992, Cancer research.

[44]  L. Spry,et al.  Metabolism and disposition of benzidine in the dog. , 1990, Carcinogenesis.

[45]  M. Butler,et al.  Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. , 1989, Cancer research.

[46]  F. Kadlubar,et al.  Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. , 1986, Carcinogenesis.

[47]  K. F. Scott,et al.  Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites. , 1984, Toxicology and applied pharmacology.

[48]  T. Zenser,et al.  Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. , 1983, Carcinogenesis.

[49]  R. Gupta,et al.  32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts. , 1982, Carcinogenesis.

[50]  C. Djerassi,et al.  Mass spectrometry of organic compounds , 1967 .

[51]  J. W. Meigs,et al.  The biotransformation of benzidine. II. Studies in mouse and man. , 1961, Archives of environmental health.